A study published in the journal Molecules highlights the potential of two cannabis-derived compounds, cannabinol (CBN) and cannabigerol (CBG), in combating acute myeloid leukemia. “Several cannabis ...

THP-1 = Human acute monocytic leukemia cell line. Disclosure: Research in Kris Chadee's laboratory is supported by grants from the Crohn's and Colitis Foundation of Canada, the Canadian Institute ...

Hyperleukocytosis is often seen in monocytic variants and can be ... DIC is also observed in patients with AML, in particular, acute promyelocytic leukemia (APL or M3-AML). These patients are ...

Morphologically, M4 acute myelomonocytic leukemia (AML) was suspected according to the French ... marrow revealed less than 1 % of myeloid precursors and less than 5 % of monocytic line presence, with ...

Human peripheral blood acute monocytic leukemia cells THP-1 (ATCC; number TIB-202) were cultured in RPMI 1640 medium (Gibco, Brazil) supplemented with 10 % FBS and 0.3 % ...

Acute and chronic leukemias and other life-threatening cancers will now be recognized as presumptive conditions for ...

Biotherapeutics company PureTech Health plc (PRTC) announced Thursday that the U.S. Food and Drug Administration (FDA) has granted ...

In a significant advancement for cancer research, a team of scientists from Max Planck Institute for Biology Tübingen, ...

Revumenib displayed promising anti-tumor activity among patients with relapsed or refractory KMT2Ar acute leukemia.

Acute myeloid leukemia (AML) is an aggressive bone marrow disease. Despite advances in treatment, AML remains a therapeutic challenge due to high rates of ...